An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe ...

A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital ...

This news release contains updated information from the researcher that was not in the abstract. CHICAGO, Nov. 18, 2024 — A new nasal spray form of the medication bumetanide may reduce the tissue ...

Doctors at North Kansas City Hospital found the same liquid in Timolol eye drops could be formed into a nasal spray.

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...

Corstasis to present pivotal trial data on Bumetanide Nasal Spray at AHA 2024, highlighting safety, and efficacy. #AHA2024.

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for several years after the initial diagnosis. A recent study by researchers at C ...

Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

Once the nasal spray is absorbed through the membranes in the nose, it enters the bloodstream and works to stimulate melanin ...

COLLEGE STATION, Texas — November is National Alzheimer's Awareness Month and now a new therapy out of Texas A&M University could treat Alzheimer's disease through a nasal spray. Seven million ...